Calamp Corp. Stock
Calamp Corp. Stock
The community is currently still undecided about Calamp Corp. with 2 Buy predictions and 0 Sell predictions.
Based on the current price of 0.13 € the target price of 6 € shows a potential of 4551.16% for Calamp Corp. which would more than double the current price.
Pros and Cons of Calamp Corp. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
B****
?
C******** o* t** e**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Calamp Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Calamp Corp. | - | - | - | - | - | - | - |
| Spok Holdings Inc. | 0.000% | 0.518% | 6.593% | -37.257% | -11.658% | -24.806% | 50.388% |
| Apt Satellite Hldgs | 0.000% | 0.000% | 0.000% | -9.524% | -24.000% | -25.197% | -20.168% |
| SmarTone Telecommunications Holdings Ltd | -0.950% | -2.804% | 0.000% | 1.961% | 5.263% | -2.804% | 7.884% |
Comments
CAMP4 Therapeutics (CAMP) was upgraded by JPMorgan Chase & Co. from "neutral" to "overweight". They now have a $9.00 price target on the stock, up from $5.00.
Show more
Ratings data for CAMP provided by MarketBeat
CAMP4 Therapeutics (CAMP) was given a new $6.50 price target by Chardan Capital. They now have a "buy" rating on the stock.
Show more
Ratings data for CAMP provided by MarketBeat
CalAmp Corp. (NASDAQ: CAMP) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for CAMP provided by MarketBeat
